Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28374) 28374
science & technology (26762) 26762
life sciences & biomedicine (23489) 23489
female (18095) 18095
male (15583) 15583
middle aged (14210) 14210
oncology (13467) 13467
aged (12076) 12076
adult (10428) 10428
cancer (10053) 10053
tumors (9685) 9685
prognosis (7584) 7584
biological and medical sciences (6707) 6707
medical sciences (6645) 6645
surgery (6505) 6505
aged, 80 and over (5091) 5091
treatment outcome (5068) 5068
medicine & public health (4993) 4993
analysis (4957) 4957
metastasis (4944) 4944
animals (4745) 4745
care and treatment (4729) 4729
retrospective studies (4522) 4522
chemotherapy (4153) 4153
neoplasm staging (4111) 4111
research (3982) 3982
patients (3758) 3758
medicine (3717) 3717
health aspects (3492) 3492
immunohistochemistry (3416) 3416
research article (3396) 3396
pathology (3382) 3382
science & technology - other topics (3281) 3281
multidisciplinary sciences (3218) 3218
breast cancer (3206) 3206
immunotherapy (3166) 3166
immunology (3165) 3165
medical prognosis (3131) 3131
follow-up studies (3040) 3040
risk factors (3010) 3010
science (2952) 2952
disease-free survival (2789) 2789
cancer therapies (2666) 2666
neoplasm recurrence, local (2656) 2656
survival rate (2640) 2640
metastases (2589) 2589
mice (2520) 2520
adolescent (2480) 2480
survival (2457) 2457
gene expression (2449) 2449
cell line, tumor (2434) 2434
gastroenterology & hepatology (2386) 2386
neoplasm recurrence, local - pathology (2318) 2318
survival analysis (2312) 2312
development and progression (2297) 2297
colorectal cancer (2268) 2268
young adult (2181) 2181
medical research (2035) 2035
abridged index medicus (2022) 2022
hematology (1988) 1988
cancer research (1928) 1928
genetic aspects (1900) 1900
cell biology (1828) 1828
combined modality therapy (1813) 1813
proteins (1803) 1803
multivariate analysis (1792) 1792
kaplan-meier estimate (1764) 1764
diagnosis (1759) 1759
breast neoplasms - pathology (1747) 1747
lymphatic metastasis (1747) 1747
antineoplastic combined chemotherapy protocols - therapeutic use (1676) 1676
child (1660) 1660
neoplasm metastasis (1656) 1656
biomarkers (1637) 1637
dermatology (1624) 1624
cancers and neoplasms (1620) 1620
studies (1612) 1612
radiation therapy (1585) 1585
antineoplastic agents - therapeutic use (1581) 1581
gene expression regulation, neoplastic (1567) 1567
time factors (1557) 1557
prostate cancer (1548) 1548
disease progression (1531) 1531
radiotherapy (1497) 1497
apoptosis (1488) 1488
gastroenterology. liver. pancreas. abdomen (1419) 1419
antineoplastic agents (1410) 1410
gastroenterology (1405) 1405
abdominal surgery (1397) 1397
medicine and health sciences (1393) 1393
neoplasm invasiveness (1391) 1391
oncology, experimental (1388) 1388
biomarkers, tumor - metabolism (1346) 1346
medicine, research & experimental (1345) 1345
research & experimental medicine (1344) 1344
prospective studies (1335) 1335
liver cancer (1329) 1329
mutation (1319) 1319
patient outcomes (1315) 1315
recurrence (1313) 1313
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (15) 15
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Online Resources - Online (2) 2
Lakeridge Health Sciences - Oshawa (1) 1
St. Michael's Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30450) 30450
Japanese (198) 198
German (115) 115
Chinese (69) 69
French (54) 54
Russian (51) 51
Spanish (34) 34
Italian (19) 19
Norwegian (15) 15
Polish (14) 14
Portuguese (14) 14
Hungarian (13) 13
Danish (9) 9
Swedish (5) 5
Czech (4) 4
Bulgarian (2) 2
Dutch (2) 2
Hebrew (2) 2
Romanian (2) 2
Arabic (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma
by Goding, Stephen R and Wilson, Kyle A and Xie, Ying and Harris, Kristina M and Baxi, Aparna and Akpinarli, Akgul and Fulton, Amy and Tamada, Koji and Strome, Scott E and Antony, Paul Andrew
The Journal of immunology (1950), ISSN 0022-1767, 05/2013, Volume 190, Issue 9, pp. 4899 - 4909
Life Sciences & Biomedicine | Immunology | Science & Technology | Forkhead Transcription Factors - immunology | Antigens, CD - immunology | T-Lymphocytes, Regulatory - metabolism | Melanoma, Experimental - metabolism | Antigens, CD - metabolism | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Melanoma, Experimental - immunology | Forkhead Transcription Factors - metabolism | Antigens, Differentiation - metabolism | Antibodies, Monoclonal - immunology | Disease Models, Animal | Apoptosis Regulatory Proteins - immunology | Neoplasm Recurrence, Local - metabolism | CD4-Positive T-Lymphocytes - metabolism | Melanoma, Experimental - pathology | B7-H1 Antigen - immunology | Apoptosis Regulatory Proteins - metabolism | B7-H1 Antigen - metabolism | Animals | Cell Line, Tumor | Programmed Cell Death 1 Receptor | Mice | Antigens, Differentiation - immunology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
by Bindea, Gabriela and Mlecnik, Bernhard and Tosolini, Marie and Kirilovsky, Amos and Waldner, Maximilian and Obenauf, Anna C and Angell, Helen and Fredriksen, Tessa and Lafontaine, Lucie and Berger, Anne and Bruneval, Patrick and Fridman, Wolf Herman and Becker, Christoph and Pagès, Franck and Speicher, Michael R and Trajanoski, Zlatko and Galon, Jérôme
Immunity (Cambridge, Mass.), ISSN 1074-7613, 10/2013, Volume 39, Issue 4, pp. 782 - 795
Life Sciences & Biomedicine | Immunology | Science & Technology | Colorectal Neoplasms - genetics | Humans | Carcinoma - mortality | Gene Expression Profiling | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Interleukins - genetics | T-Lymphocytes, Helper-Inducer - immunology | Interleukins - immunology | T-Lymphocytes, Helper-Inducer - pathology | B-Lymphocytes - pathology | Protein Stability | Carcinoma - pathology | Chemokine CXCL13 - immunology | Colorectal Neoplasms - mortality | Chemokine CXCL13 - genetics | Carcinoma - immunology | Gene Expression Regulation | Immunity, Innate | Tumor Microenvironment - immunology | Animals | B-Lymphocytes - immunology | Colorectal Neoplasms - immunology | Survival Analysis | Lymphocyte Count | Carcinoma - genetics | Neoplasm Recurrence, Local - genetics | Mice | Colorectal Neoplasms - pathology | Neoplasm Staging | Cell Movement | Cancer | Medical research | Cytotoxicity | Genomes | Genetic diversity | Gene expression | Experiments | Patients | Lymphocytes | Rodents | Medical prognosis | Colon | Immune system | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer
by Swaminathan, Suresh Kumar and Roger, Emilie and Toti, Udaya and Niu, Lin and Ohlfest, John R and Panyam, Jayanth
Journal of controlled release, ISSN 0168-3659, 11/2013, Volume 171, Issue 3, pp. 280 - 287
Sustained release | Polymeric nanoparticles | Cancer stem cells | Targeted delivery | Cancer initiating cells | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Antibodies, Immobilized - chemistry | Antigens, CD - immunology | Antibodies, Immobilized - immunology | Nanoparticles - chemistry | Breast Neoplasms - immunology | Humans | Neoplasm Recurrence, Local - drug therapy | Paclitaxel - pharmacokinetics | Drug Carriers - chemistry | Drug Delivery Systems | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Antineoplastic Agents, Phytogenic - administration & dosage | Female | Antineoplastic Agents, Phytogenic - therapeutic use | Paclitaxel - administration & dosage | Antineoplastic Agents, Phytogenic - pharmacokinetics | Breast - pathology | Caco-2 Cells | Breast - immunology | Peptides - immunology | AC133 Antigen | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Glycoproteins - immunology | Animals | Breast - drug effects | Breast Neoplasms - pathology | Cell Line, Tumor | Mice | Mice, Inbred BALB C | Antimitotic agents | Care and treatment | Analysis | Monoclonal antibodies | Breast cancer | Drug resistance | Antineoplastic agents | Cancer | Index Medicus | Animal models
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence
by Chevalier, Mathieu F and Trabanelli, Sara and Racle, Julien and Salomé, Bérengère and Cesson, Valérie and Gharbi, Dalila and Bohner, Perrine and Domingos-Pereira, Sonia and Dartiguenave, Florence and Fritschi, Anne-Sophie and Speiser, Daniel E and Rentsch, Cyrill A and Gfeller, David and Jichlinski, Patrice and Nardelli-Haefliger, Denise and Jandus, Camilla and Derré, Laurent
The Journal of clinical investigation, ISSN 0021-9738, 08/2017, Volume 127, Issue 8, pp. 2916 - 2929
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Neutrophils - cytology | Urinary Bladder Neoplasms - urine | Prospective Studies | Monocytes - cytology | Humans | Middle Aged | Neoplasm Recurrence, Local - urine | Male | Lymphocytes - cytology | Interleukin-13 - metabolism | Neoplasm Recurrence, Local - immunology | Disease-Free Survival | Immune System | T-Lymphocytes - cytology | BCG Vaccine | Immunotherapy | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - immunology | Aged, 80 and over | Female | Aged | Administration, Intravesical | Longitudinal Studies | Relapse | Cellular signal transduction | Research | T cells | Bladder cancer | Diseases | Leprosy | Lymphocytes T | Suppressor cells | Metastases | Genotype & phenotype | Urinary bladder | Lymphocytes | Rodents | Urine | Antigens | Lymphoid cells | Cell survival | Tumor cells | Invasiveness | Neutrophils | BCG | Leukocytes (neutrophilic) | Interleukin 13 | Gene expression | Patients | Survival analysis | Monocytes | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
by Sayour, Elias J and McLendon, Pat and McLendon, Roger and De Leon, Gabriel and Reynolds, Renee and Kresak, Jesse and Sampson, John H and Mitchell, Duane A
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 03/2015, Volume 64, Issue 4, pp. 419 - 427
Regulatory T cells (Tregs) | Primary and recurrent GBM | Tumor infiltrating lymphocytes | Immunotherapy | Oncology | Immunology | Life Sciences & Biomedicine | Science & Technology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | Male | Neoplasm Recurrence, Local - mortality | Immunoenzyme Techniques | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Brain Neoplasms - immunology | Forkhead Transcription Factors - metabolism | Biomarkers, Tumor - metabolism | Adult | Female | Brain Neoplasms - mortality | Survival Rate | Glioblastoma - immunology | Glioblastoma - pathology | Aged | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | Glioblastoma - mortality | Lymphocytes, Tumor-Infiltrating - immunology | Immunohistochemistry | Care and treatment | Relapse | Analysis | Patient outcomes | T cells | Glioblastoma multiforme | Cells | Diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
by Motomura, Takashi and Shirabe, Ken and Mano, Yohei and Muto, Jun and Toshima, Takeo and Umemoto, Yuichiro and Fukuhara, Takasuke and Uchiyama, Hideaki and Ikegami, Toru and Yoshizumi, Tomoharu and Soejima, Yuji and Maehara, Yoshihiko
Journal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 1, pp. 58 - 64
Gastroenterology and Hepatology | TAM | HCC | IL 17 | NLR | Liver transplantation | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Neutrophils - cytology | Predictive Value of Tests | Carcinoma, Hepatocellular - mortality | Prognosis | Humans | Middle Aged | Male | Vascular Endothelial Growth Factor A - metabolism | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - immunology | Young Adult | Adult | Female | Carcinoma, Hepatocellular - immunology | Interleukin-8 - metabolism | Risk Factors | Kaplan-Meier Estimate | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - immunology | Liver Neoplasms - surgery | Liver Transplantation - mortality | Lymphocytes - cytology | Macrophages - cytology | Preoperative Care | Tumor Microenvironment - immunology | Disease-Free Survival | Interleukin-17 - metabolism | Lymphocyte Count | Aged | Liver cancer | C-reactive protein | Liver | Transplantation | Hepatoma | Vascular endothelial growth factor | Donation of organs, tissues, etc | Enzyme-linked immunosorbent assay | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text PD‐1 and PD‐L1 upregulation promotes CD8+ T‐cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
by Shi, Feng and Shi, Ming and Zeng, Zhen and Qi, Rui‐Zhao and Liu, Zhen‐Wen and Zhang, Ji‐Yuan and Yang, Yong‐Ping and Tien, Po and Wang, Fu‐Sheng
International journal of cancer, ISSN 0020-7136, 02/2011, Volume 128, Issue 4, pp. 887 - 896
apoptosis | PD‐1 | hepatocellular carcinoma | PD‐L1 | PD-L1 | PD-1 | Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Biological and medical sciences | Medical sciences | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Tumors | Liver Cirrhosis - immunology | Up-Regulation | Liver - pathology | Cell Proliferation | Humans | Middle Aged | Male | Interferon-gamma - metabolism | Immunoenzyme Techniques | Antigens, CD - metabolism | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Young Adult | Liver - immunology | Flow Cytometry | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - immunology | Postoperative Complications | Enzyme-Linked Immunosorbent Assay | B7-H1 Antigen | RNA, Messenger - genetics | Liver Neoplasms - immunology | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | CD8-Positive T-Lymphocytes - physiology | Disease Progression | Apoptosis Regulatory Proteins - metabolism | Carcinoma, Hepatocellular - pathology | Liver Cirrhosis - pathology | Programmed Cell Death 1 Receptor | Aged | Apoptosis | Cirrhosis | Immune response | PD-1 protein | CD8 antigen | PD-L1 protein | Effector cells | Cytotoxicity | Hepatocellular carcinoma | Lymphocytes T | Hepatoma | Hepatitis B | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study
by Aziz, Mohammad Hosein and Sideras, Kostandinos and Aziz, Nasir Ahmad and Mauff, Katya and Haen, Roel and Roos, Daphne and Saida, Lawlaw and Suker, Mustafa and van der Harst, Erwin and Mieog, Jan Sven and Bonsing, Bert A and Klaver, Yarne and Koerkamp, Bas Groot and van Eijck, Casper H
Annals of surgery, ISSN 0003-4932, 07/2019, Volume 270, Issue 1, pp. 139 - 146
Life Sciences & Biomedicine | Surgery | Science & Technology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Carcinoma, Pancreatic Ductal - surgery | Inflammation - blood | Neoplasm Recurrence, Local - immunology | Aged, 80 and over | Adult | Carcinoma, Pancreatic Ductal - mortality | Female | Pancreatic Neoplasms - mortality | Retrospective Studies | Inflammation - diagnosis | Carcinoma, Pancreatic Ductal - immunology | Severity of Illness Index | Pancreatic Neoplasms - blood | Reproducibility of Results | Pancreatic Neoplasms - surgery | Pancreatectomy | Neoplasm Recurrence, Local - diagnosis | Inflammation - etiology | Biomarkers, Tumor - blood | Carcinoma, Pancreatic Ductal - blood | Bilirubin - blood | Pancreatic Neoplasms - immunology | Aged | Usage | Care and treatment | Pancreatic cancer | Bilirubin | Research | Excision (Surgery) | Immune system | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights